ONI
Mike Benchimol has a diverse work experience spanning multiple industries. Mike most recently worked as the Director of Hardware at ONI since July 2023. Prior to that, they held various roles at NanoCellect Biomedical, Inc., including Senior Director of Engineering, Director of Product Development, Director of Operations, and Product Manager. Before that, they were the Founder and Chief Technology Officer at Sonrgy, Inc., where they pioneered the development of ultrasound-responsive nanomedicine for safer chemotherapy. Mike also served as the Chief Engineer and Principal Investigator at Diagnologix, LLC, leading the research and development of a novel cell-isolation technology. Mike Benchimol has a strong academic background, having worked as a Post-doc at UC San Diego and as a Graduate Researcher at UCSD Moores Cancer Center. Additionally, they have experience as an Engineering Consultant at Engineered Medical Devices and as the Director of Judging at the UC San Diego Entrepreneur Challenge.
Mike Benchimol completed their education in a chronological order. Mike started by earning a Bachelor of Science (BS) degree in Electrical Engineering from Boston University, where they studied from 2002 to 2006. Subsequently, they pursued a Master of Science (MS) degree in Photonics at UC San Diego from 2006 to 2008. Finally, they obtained their highest degree, a Doctorate (PhD), from UC San Diego, specializing in Ultrasound-Responsive Particles for Cancer Diagnostics and Therapeutics, which they completed from 2008 to 2012.
This person is not in any teams
ONI
7 followers
ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal. The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard. ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.